207_Combined course Presentations

Adjuvant chemo studies

Study

Pats Adv stage

Treatment 5-yr OS

RT RT+ A/P/T

74% 82% 86% 87% 69% 66% 42% 55%

382 Stage I-III 385 Stage I-III 340 Stage I-III 396 Stage III-IV

NSGO-EORTC Hogberg 2007

2%

RT CAP RT CAP

J GOG 2033 Sagae 2005

25%

GICOG Maggi 2006

64%

WART AP

GOG 122 Randall 2006

100%

van Wijk FH, et al. Int J Gynecol Cancer. 2009;19(3):431-46